Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modifier-Sensitive Phenotypic Divergence in XMEN Disease (MAGT1 Deficiency): Neurodegenerative and Immuno-Hematologic Trajectories.

Journal of clinical medicine·2026
Same author

Should We Adopt Increased Dilutions for Indirect Immunofluorescence in Pediatric Anti-Centromere Antibody Testing? Insights from a Three-Year Retrospective Study.

Children (Basel, Switzerland)·2025
Same author

COVID-19 Antibody Levels among Various Vaccination Groups, One-Year Antibody Follow-Up in Two University Hospitals from Western and Central Turkey.

Vaccines·2024
Same author

Efficacy of coronavirus disease 2019 vaccines in patients with rheumatic diseases.

Archives of rheumatology·2023

Related Experiment Video

Updated: Jan 14, 2026

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

37.1K

Recognizing IgA-class endomysial antibody equivalent binding patterns on monkey liver substrate through EfficientNet

Mehmet Soylu1, Ahmet Selman Bozkir2

  • 1Department of Medical Microbiology, Ege University, İzmir, Turkey.

Peerj
|October 20, 2025
PubMed
Summary
This summary is machine-generated.

Deep learning models, specifically EfficientNetV2-S, show high accuracy in interpreting immunoglobulin A (IgA) endomysial antibody (EMA) tests for celiac disease diagnosis. These AI tools offer a path toward more objective and efficient diagnostic processes.

Keywords:
Celiac diagnosisComputer visionIgA endomysial antibody testsMachine learning

More Related Videos

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

14.5K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

13.0K

Related Experiment Videos

Last Updated: Jan 14, 2026

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate
10:05

Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate

Published on: January 17, 2018

37.1K
Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
11:10

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study

Published on: June 29, 2016

14.5K
Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
08:51

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing

Published on: March 15, 2019

13.0K

Area of Science:

  • Medical Diagnostics
  • Artificial Intelligence in Medicine
  • Immunology

Background:

  • Immunoglobulin A (IgA) endomysial antibody (EMA) testing is crucial for diagnosing celiac disease.
  • Current EMA test interpretation is subjective and labor-intensive, requiring expert human analysis.
  • Automating EMA test interpretation using deep learning could enhance diagnostic efficiency and objectivity.

Purpose of the Study:

  • To evaluate the performance of EfficientNet and EfficientNetV2 deep learning architectures for automated IgA EMA test interpretation.
  • To assess classification accuracy across binary, three-class, and four-class scenarios, including gray zone cases.
  • To explore the potential of explainable AI (HiRes-CAM) in understanding deep learning model decisions for EMA-eq tests.

Main Methods:

  • Utilized EfficientNet and EfficientNetV2 architectures for image classification of IgA EMA equivalent (EMA-eq) tests.
  • Trained and tested models on 368 clinical samples across different classification tasks (binary, three-class, four-class).
  • Employed HiRes-CAM for visualizing and explaining the deep learning model's interpretation process.

Main Results:

  • EfficientNetV2-S achieved high accuracy: 99.37% (binary), 95.28% (three-class), and 86.98% (four-class).
  • Medium-sized deep learning architectures outperformed larger ones, contrary to expectations.
  • Higher input resolution (640x640) and architectural innovations in EfficientNet-V2 contributed to superior performance.

Conclusions:

  • Deep learning models can achieve expert-level performance in interpreting IgA EMA-eq tests.
  • Automated interpretation offers a more standardized, efficient, and objective approach to celiac disease diagnosis.
  • This technology has the potential to reduce the workload on specialist medical staff.